Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and ...

A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.

Curcumin may stop or slow key chemicals associated with inflammation. Piperine in black pepper can increase curcumin bioavailability by up to 2,000%. Turmeric or curcumin supplements are available as ...